Page last updated: 2024-10-30

loxoprofen and Sjogren's Syndrome

loxoprofen has been researched along with Sjogren's Syndrome in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamada, S1
Nagafuchi, Y1
Fujio, K1

Other Studies

1 other study available for loxoprofen and Sjogren's Syndrome

ArticleYear
Retro-odontoid Pseudotumor Associated with Sjögren Syndrome and Systemic Lupus Erythematosus Serology.
    The Journal of rheumatology, 2018, Volume: 45, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Humans; Lupus Coagulation Inhibitor; Lupus Erythemat

2018